The role of stem cells in the treatment of retinitis pigmentosa: Contemporary insights and future perspectives

Retinitis pigmentosa (RP) is a hereditary degenerative disorder distinguished by the gradual deterioration of retinal pigment epithelium (RPE) cells and photoreceptors. This condition typically presents with gradual night blindness, difficulties in color perception, central vision impairment, and ul...

Full description

Saved in:
Bibliographic Details
Main Author: Wang Shiqi
Format: Article
Language:English
Published: EDP Sciences 2025-01-01
Series:BIO Web of Conferences
Online Access:https://www.bio-conferences.org/articles/bioconf/pdf/2025/25/bioconf_icbb2025_01002.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850152341817262080
author Wang Shiqi
author_facet Wang Shiqi
author_sort Wang Shiqi
collection DOAJ
description Retinitis pigmentosa (RP) is a hereditary degenerative disorder distinguished by the gradual deterioration of retinal pigment epithelium (RPE) cells and photoreceptors. This condition typically presents with gradual night blindness, difficulties in color perception, central vision impairment, and ultimately leads to blindness, predominantly affecting younger individuals. The irreversible loss of retinal cells poses significant challenges in the treatment of RP. Due to their distinctive potential to differentiate into various retinal cell types, stem cells have emerged as a promising therapeutic strategy for RP. Among the categories of stem cells under investigation, embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and mesenchymal stem cells (MSCs) are particularly prominent. In particular, bone marrow-derived MSCs (BM- MSCs) have shown both safety and efficacy in enhancing visual sharpness and retinal thickness in affected individuals. Moreover, recent studies have highlighted the differentiation potential of Müller glial cells into photoreceptor cells, broadening the scope for treatment. The incorporation of advanced bioengineering techniques-such as 3D bioprinting and gene editing-further enhances the prospects for innovative therapies. Despite significant progress in animal experiments and clinical trials, challenges remain, including uncertainties in cellular differentiation and complications arising from multifaceted retinal pathologies. This review aims to synthesize current insights into stem cell therapy for RP, emphasizing both achievements and ongoing challenges in the pursuit of effective treatments.
format Article
id doaj-art-e02d45b5a8c84e5f9a4a482a01dbed51
institution OA Journals
issn 2117-4458
language English
publishDate 2025-01-01
publisher EDP Sciences
record_format Article
series BIO Web of Conferences
spelling doaj-art-e02d45b5a8c84e5f9a4a482a01dbed512025-08-20T02:26:01ZengEDP SciencesBIO Web of Conferences2117-44582025-01-011740100210.1051/bioconf/202517401002bioconf_icbb2025_01002The role of stem cells in the treatment of retinitis pigmentosa: Contemporary insights and future perspectivesWang Shiqi0School of Ophthaimology & Optometry (School of Biomedical Engineering), Wenzhou Medical UniversityRetinitis pigmentosa (RP) is a hereditary degenerative disorder distinguished by the gradual deterioration of retinal pigment epithelium (RPE) cells and photoreceptors. This condition typically presents with gradual night blindness, difficulties in color perception, central vision impairment, and ultimately leads to blindness, predominantly affecting younger individuals. The irreversible loss of retinal cells poses significant challenges in the treatment of RP. Due to their distinctive potential to differentiate into various retinal cell types, stem cells have emerged as a promising therapeutic strategy for RP. Among the categories of stem cells under investigation, embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and mesenchymal stem cells (MSCs) are particularly prominent. In particular, bone marrow-derived MSCs (BM- MSCs) have shown both safety and efficacy in enhancing visual sharpness and retinal thickness in affected individuals. Moreover, recent studies have highlighted the differentiation potential of Müller glial cells into photoreceptor cells, broadening the scope for treatment. The incorporation of advanced bioengineering techniques-such as 3D bioprinting and gene editing-further enhances the prospects for innovative therapies. Despite significant progress in animal experiments and clinical trials, challenges remain, including uncertainties in cellular differentiation and complications arising from multifaceted retinal pathologies. This review aims to synthesize current insights into stem cell therapy for RP, emphasizing both achievements and ongoing challenges in the pursuit of effective treatments.https://www.bio-conferences.org/articles/bioconf/pdf/2025/25/bioconf_icbb2025_01002.pdf
spellingShingle Wang Shiqi
The role of stem cells in the treatment of retinitis pigmentosa: Contemporary insights and future perspectives
BIO Web of Conferences
title The role of stem cells in the treatment of retinitis pigmentosa: Contemporary insights and future perspectives
title_full The role of stem cells in the treatment of retinitis pigmentosa: Contemporary insights and future perspectives
title_fullStr The role of stem cells in the treatment of retinitis pigmentosa: Contemporary insights and future perspectives
title_full_unstemmed The role of stem cells in the treatment of retinitis pigmentosa: Contemporary insights and future perspectives
title_short The role of stem cells in the treatment of retinitis pigmentosa: Contemporary insights and future perspectives
title_sort role of stem cells in the treatment of retinitis pigmentosa contemporary insights and future perspectives
url https://www.bio-conferences.org/articles/bioconf/pdf/2025/25/bioconf_icbb2025_01002.pdf
work_keys_str_mv AT wangshiqi theroleofstemcellsinthetreatmentofretinitispigmentosacontemporaryinsightsandfutureperspectives
AT wangshiqi roleofstemcellsinthetreatmentofretinitispigmentosacontemporaryinsightsandfutureperspectives